SCHEMBL13490744

SCHEMBL13490744

C/C(=N\OCc1ccccc1-n1c(CO)nn(C)c1=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
PPARG P37231 3/20 0.37
PPARA Q07869 3/20 0.37
GAA P10253 3/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
BRD9 Q9H8M2 1/20 0.34
LMNA P02545 1/20 0.34
TLR7 Q9NYK1 1/20 0.33
TBXA2R P21731 2/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9049388 0.90 KMT2A (0.38) KMT2AMEN1PPARGPPARAGAA
SCHEMBL9049391 0.90 KMT2A (0.38) KMT2AMEN1PPARGPPARAGAA
SCHEMBL8665322 0.89 PPARG (0.38) KMT2AMEN1PPARGPPARAGAA
SCHEMBL8658637 0.89 PPARG (0.38) KMT2AMEN1PPARGPPARAGAA
SCHEMBL119998 0.88 KMT2A (0.37) KMT2AMEN1PPARGPPARAGAA
SCHEMBL119997 0.88 KMT2A (0.37) KMT2AMEN1PPARGPPARAGAA
SCHEMBL32678199 0.88 KMT2A (0.37) KMT2AMEN1PPARGPPARAGAA
SCHEMBL959562 0.88 KMT2A (0.37) KMT2AMEN1PPARGPPARAGAA
SCHEMBL29870686 0.88 KMT2A (0.37) KMT2AMEN1PPARGPPARAGAA
SCHEMBL9050974 0.84 KMT2A (0.39) KMT2AMEN1PPARGPPARAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048546-A1 FUNGICIDAL COMBINATIONS COMPRISING A GLYOXALIC ACID METHYL ESTER-O-METHYLOXIME DERIVATIVES ZURFLUEH RENE 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048546-A1 FUNGICIDAL COMBINATIONS COMPRISING A GLYOXALIC ACID METHYL ESTER-O-METHYLOXIME DERIVATIVES GLO1, AGXT, GNMT KMT2A 740/4885MEN1 1765/4885PPARG 1270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.